Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chantal Ferguson

Showing results (11-20 of 18) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 18 results.
Research Square|May 2, 2025
Single-dose administration of therapeutic divalent siRNA targeting MECP2 prevents lethality for one year in an MECP2 duplication mouse modelVignesh N Hariharan, Ashley Summers, Amy E Clipperton-Allen, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|September 26, 2023
Di-valent siRNA-mediated silencing of MSH3 blocks somatic repeat expansion in mouse models of Huntington's diseaseDaniel O'Reilly, Jillian Belgrad, Chantal Ferguson, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|May 13, 2023
Di-valent siRNA-mediated silencing of MSH3 blocks somatic repeat expansion in mouse models of Huntington's diseaseDaniel O'Reilly, Jillian Belgrad, Chantal Ferguson, et al.
Research Square|July 3, 2023
Extended Nucleic Acid (exNA): A Novel, Biologically Compatible Backbone that Significantly Enhances Oligonucleotide Efficacy in vivoVignesh Narayan Hariharan, Jillian Caiazzi, Rachael Miller, et al.
Biorxiv : the Preprint Server for Biology|July 9, 2024
RNAi-mediated silencing of SOD1 profoundly extends survival and functional outcomes in ALS miceAlexandra Weiss, James W Gilbert, Iris Valeria Rivera Flores, et al.
Nucleic Acids Research|June 23, 2025
Systematic analysis of siRNA and mRNA features impacting fully chemically modified siRNA efficacySarah M Davis, Samuel Hildebrand, Hannah J MacMillan, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|May 11, 2025
RNAi-mediated silencing of SOD1 profoundly extends survival and functional outcomes in ALS miceAlexandra Weiss, James W Gilbert, Iris Valeria Rivera Flores, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 9, 2023
Divalent siRNAs are bioavailable in the lung and efficiently block SARS-CoV-2 infectionVignesh N Hariharan, Minwook Shin, Ching-Wen Chang, et al.
Pageof 2

Showing results (11-20 of 18) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 18 results.
Research Square|May 2, 2025
Single-dose administration of therapeutic divalent siRNA targeting MECP2 prevents lethality for one year in an MECP2 duplication mouse modelVignesh N Hariharan, Ashley Summers, Amy E Clipperton-Allen, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|September 26, 2023
Di-valent siRNA-mediated silencing of MSH3 blocks somatic repeat expansion in mouse models of Huntington's diseaseDaniel O'Reilly, Jillian Belgrad, Chantal Ferguson, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|May 13, 2023
Di-valent siRNA-mediated silencing of MSH3 blocks somatic repeat expansion in mouse models of Huntington's diseaseDaniel O'Reilly, Jillian Belgrad, Chantal Ferguson, et al.
Research Square|July 3, 2023
Extended Nucleic Acid (exNA): A Novel, Biologically Compatible Backbone that Significantly Enhances Oligonucleotide Efficacy in vivoVignesh Narayan Hariharan, Jillian Caiazzi, Rachael Miller, et al.
Biorxiv : the Preprint Server for Biology|July 9, 2024
RNAi-mediated silencing of SOD1 profoundly extends survival and functional outcomes in ALS miceAlexandra Weiss, James W Gilbert, Iris Valeria Rivera Flores, et al.
Nucleic Acids Research|June 23, 2025
Systematic analysis of siRNA and mRNA features impacting fully chemically modified siRNA efficacySarah M Davis, Samuel Hildebrand, Hannah J MacMillan, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|May 11, 2025
RNAi-mediated silencing of SOD1 profoundly extends survival and functional outcomes in ALS miceAlexandra Weiss, James W Gilbert, Iris Valeria Rivera Flores, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 9, 2023
Divalent siRNAs are bioavailable in the lung and efficiently block SARS-CoV-2 infectionVignesh N Hariharan, Minwook Shin, Ching-Wen Chang, et al.
Pageof 2